American Shared Hospital Services (NYSE Amex:AMS) today announced financial results for the second quarter and first half of 2012. For the 3 months ended June 30, 2012, revenue rose 1.9% to $4,284,000 compared to $4,206,000 for the 2nd quarter of 2011. Net income for the 2nd quarter of 2012 was $15,000, or $0.00 per diluted share. This compares to net income of $21,000, or $0.00 per diluted share, for the 2nd quarter of 2011.
American Shared Hospital Services, along with its subsidiaries, leases radiation therapy and radiosurgery equipment and services to medical centers in the United States.
Bovie Medical Corporation (NYSE Amex:BVX) recently announced that J-Plasma is performing well in both laparoscopic and open surgeries. In multiple patient procedures there was a decrease in smoke, less charring and overall excellent tissue response when compared to current electrosurgery devices.
Bovie Medical Corporation is a manufacturer and marketer of electrosurgical products.
China Botanic Pharmaceutical Inc. (NYSE Amex:CBP) recently announced that the Company was granted a new patent (Patent No: ZL 201010119871.7) on its Schisandra Lignin Extraction Method that is an advanced proprietary.
China Botanic Pharmaceutical Inc. is a manufacturer, developer, and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China.
Inovio Pharmaceuticals Inc. (NYSE Amex:INO) recently announced that their August 2nd RetailInvestorConferences.com presentation is now available for on-demand viewing. Inovio Pharmaceuticals Inc.’s presentation will be available 24/7 for 90 days. Investors can download shareholder materials from the “virtual trade booth” for the next 3 weeks.
Inovio is preventing and treating today’s cancers and challenging infectious diseases with revolutionizing vaccines.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. galaxystocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://galaxystocks.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold galaxystocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here